دستورالعمل ارسال مقالات

2. Submission Regulations

• • • Abstract submission deadline for ISRO 2023 is on January 12, 2023.
    • Abstracts must be submitted online via the http://submit.iscocongress.com.
    • In case of abstract withdrawal, please submit your requests in writing via email to farazmand@iscocongress.com by January 18, 2023, with your submission ID number(s).
    • For any questions regarding the online submission process, please email farazmand@iscocongress.com.

3. Aim and Scope

3.1. Clinical abstracts:

• • • Breast cancer
    • CNS tumors
    • Cancer management in COVID-19 era
    • Cancer screening
    • Endocrine and neuroendocrine tumors
    • Gastrointestinal cancers
    • Genitourinary cancers
    • Gynecology cancers
    • Head and neck cancers
    • Hematological malignancies
    • Lung cancers
    • Palliative care
    • Psyco-oncology
    • Pediatric tumors
    • Sarcoma
    • Skin cancers

3.2. Physics abstracts:

3.3. Radiobiology abstracts:

• • • Normal tissue radiobiology
    • Tumor radiobiology
    • Immuno-radiobiology
    • Microenvironment

3.4. RTT abstracts:

4. Criteria for acceptance

4.1. Originality:

By submitting an abstract intended for presentation at ISRO 2023, the first author (= presenter) warrants that the materials have not been previously published in any publication (in peer review setting) before February 15, 2023.

4.2. Accepted manuscript formats

• • • Original research
    • Systematic review
    • Meta-analysis
    • We will not consider:
      • Reviews
      • Case reports/case series
      • Hypothesis or proposal papers
      • Letters, commentaries, or essays
      • Opinion pieces
      • Policy papers
      • Clinical practice guidelines
      • Any other type of secondary literature
      • Monographs

4.3. Abstract structure

• • • Author names and affiliations should not be present in the abstract title and abstract content as the abstract must be blinded for review.
    • The title of the abstract should include significant keywords that reflect the content of the abstract
    • Abstracts must not exceed 350 words. Deduct 50 words for each table, graphs or figures included. For example, with two figures, the maximum word count is 250.
    • Images are not permitted as they do not reproduce well. Brief and clear tables, graphs, and figures are accepted (maximum of 1 page on US Letter, 8.5 x 11-inch paper).
    • The abstract is presented in an intelligible fashion and is written in standard English
    • The abstract must include the main headings of Background and Objectives, Methods, Results, and Conclusions
    • Methods cover the main experiments and analysis (if any)
    • Results cover the findings on primary (and secondary, if any) objective
    • Conclusions are presented in an appropriate fashion and are supported by the data
    • Use generic terms for drug names
    • Standard abbreviations may be used without definition. Nonstandard abbreviations should be kept to a minimum and placed in parentheses after the first use of the word or phrase
    • Use International System (SI) for units

5. Review Process

• • • Each abstract will be blinded and scored by up to two reviewers.
    • The reviewers are selected based on the abstract category (clinical, physics, radiobiology, RTT)
    • Abstracts will be accepted on the basis of scientific merit and originality.
    • Overall, bear in mind that your abstract will be rated according to the following criteria:
    • is the design of the study valid?
    • are the methods appropriate?
    • what is the significance of the results?